Why Personalized Medicine Matters

by John Audette | Oct 31, 2015 | Marketing, Regulation

President Obama is pushing the term "Precision Medicine."

Introducing the Personalized Medicine Scorecard™: Drug Companies Edition

We have just completed our first ranking of biopharma companies based on how much they are driving innovation in personalized medicine, and Genentech scored the highest among 25 companies. Download the scorecard whitepaper:

73% Growth in the Use of Companion Diagnostic Biomarkers

- Metabolism biomarker testing dominates companion diagnostic (CDx) use

Is Personalized Medicine Being Properly/Fully Utilized?

An article published in Nature last month describes a recent trend in which “oncologists are starting to prescribe expensive new drugs that target the genetic profiles of their patients’ tumors, even when those treatments have not been approved for the particular cancer involved.” Such "off-label" ...




Pharmacovigilance and Safety Biomarkers

New Call-to-action

Subscribe for Updates

Download our Free IVD Trends Report